Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy
Authors
Keywords
-
Journal
Birth Defects Research
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-18
DOI
10.1002/bdr2.2260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy—analysis of registry data
- (2021) Raphaël Porcher et al. EUROPEAN HEART JOURNAL
- Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy–related cardiomyopathy
- (2021) Alexander P. Murphy et al. MUSCLE & NERVE
- Left ventricular dysfunction in Duchenne muscular dystrophy
- (2020) Katherine A. James et al. CARDIOLOGY IN THE YOUNG
- Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy
- (2020) Carol A. Wittlieb-Weber et al. PEDIATRIC CARDIOLOGY
- Cardiorespiratory progression over 5 years and role of corticosteroids in DMD: a single site retrospective longitudinal study
- (2020) Federica Trucco et al. CHEST
- Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial
- (2019) Sven Dittrich et al. Orphanet Journal of Rare Diseases
- Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- IMAGING THE HEART TO DETECT CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY: A REVIEW
- (2018) Lisa C. Power et al. NEUROMUSCULAR DISORDERS
- Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study
- (2018) Tadao Aikawa et al. PEDIATRIC CARDIOLOGY
- Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy
- (2017) Sunkyung Kim et al. NEUROMUSCULAR DISORDERS
- Predictors of Death in Adults With Duchenne Muscular Dystrophy–Associated Cardiomyopathy
- (2017) Daniel Cheeran et al. Journal of the American Heart Association
- Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy
- (2017) Marly Conceição Silva et al. JAMA Cardiology
- Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging
- (2016) Jonathan H. Soslow et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy
- (2016) Sujatha Buddhe et al. PEDIATRIC RADIOLOGY
- Contemporary Cardiac Issues in Duchenne Muscular Dystrophy: Table.
- (2015) Elizabeth M. McNally et al. CIRCULATION
- Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies
- (2015) Christopher F. Spurney et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial
- (2015) Subha V Raman et al. LANCET NEUROLOGY
- Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
- (2015) P. A. Romitti et al. PEDIATRICS
- Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy
- (2015) A. Tandon et al. Journal of the American Heart Association
- Cooperative international neuromuscular research group duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in duchenne muscular dystrophy
- (2014) Christopher Spurney et al. MUSCLE & NERVE
- Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction
- (2013) Srinivas R. Bapoje et al. Circulation-Heart Failure
- Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy
- (2013) Brent J. Barber et al. JOURNAL OF PEDIATRICS
- All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
- (2013) Gernot Schram et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
- (2012) Laurence Viollet et al. AMERICAN JOURNAL OF CARDIOLOGY
- Carvedilol can Prevent Cardiac Events in Duchenne Muscular Dystrophy
- (2010) Tsuyoshi Matsumura et al. INTERNAL MEDICINE
- Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Case Definition in Surveillance for Childhood-Onset Duchenne/Becker Muscular Dystrophy
- (2010) Katherine D. Mathews et al. JOURNAL OF CHILD NEUROLOGY
- Hereditary muscular dystrophies and the heart
- (2010) M.C.E. Hermans et al. NEUROMUSCULAR DISORDERS
- Echocardiographic Evaluation of Children With Systemic Ventricular Dysfunction Treated With Carvedilol
- (2010) Colin Petko et al. PEDIATRIC CARDIOLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: A magnetic resonance imaging study
- (2008) Sophie Mavrogeni et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy
- (2008) Hitoko Ogata et al. Journal of Cardiology
- Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy
- (2008) Larry W. Markham et al. NEUROMUSCULAR DISORDERS
- Deflazacort Use in Duchenne Muscular Dystrophy: An 8-Year Follow-Up
- (2008) Sylvie Houde et al. PEDIATRIC NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now